Cumberland Pharmaceuticals Inc. CPIX
7.61
(0.40)
(4.99%)
as of 25 Sep
- Market cap
- $120.0M
- P/E
- 0.0×
Follow CPIX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.33 | 0.88 | 0.67 | 0.80 | 1.93 | 1.19 | 2.31 | 3.21 | 2.73 | 2.88 |
P/FCF ratio |
12.45 | 0.00 | 4.69 | 5.27 | 11.62 | 13.55 | 38.92 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
19,707.63 | 17.50 | 25.43 | 9.25 | 35.52 | 52.37 | 92.52 | 25.29 | (244.13) | 116.06 |
P/B ratio |
2.41 | 1.48 | 0.90 | 0.94 | 1.63 | 0.95 | 1.55 | 1.69 | 1.76 | 1.30 |
Price to Tangible BV |
2.41 | 9.11 | 4.61 | 7.53 | 3.92 | 2.50 | 4.11 | 4.46 | 2.64 | 1.87 |
EV/Sales |
1.30 | 0.81 | 0.54 | 0.72 | 1.63 | 0.96 | 2.05 | 2.66 | 1.75 | 1.49 |
EV/EBITDA |
42.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.96 |
EV/Operating CF |
11.76 | (50.04) | 3.49 | 3.58 | 9.23 | 6.65 | 23.07 | 25.03 | (128.91) | 86.24 |
EV/FCF |
12.21 | (38.68) | 3.77 | 4.74 | 9.78 | 10.90 | 34.60 | (67.04) | (35.13) | (31.45) |
Quick Ratio |
0.77 | 0.94 | 1.00 | 1.15 | 1.76 | 1.45 | 1.49 | 1.59 | 3.31 | 3.88 |
Current Ratio |
1.01 | 1.15 | 1.28 | 1.61 | 2.37 | 1.95 | 2.08 | 2.13 | 3.88 | 4.43 |
Net Debt/EBITDA |
(4.58) | 1.76 | 4.34 | 8.98 | 3.60 | 5.35 | 1.80 | 1.98 | 28.10 | (47.76) |
Debt/Assets |
6.82% | 20.21% | 15.63% | 17.62% | 18.91% | 16.60% | 18.58% | 17.75% | 10.51% | 4.39% |
Debt/Equity |
0.21 | 0.68 | 0.44 | 0.46 | 0.37 | 0.34 | 0.38 | 0.36 | 0.15 | 0.06 |
Asset Turnover |
0.58 | 0.48 | 0.45 | 0.47 | 0.40 | 0.37 | 0.32 | 0.29 | 0.44 | 0.36 |
Operating CF/Net income |
(1.74) | 0.09 | (0.97) | (1.52) | (1.81) | (1.62) | (0.86) | (0.45) | 0.07 | (0.60) |
Capex/Depreciation |
(0.04) | (0.04) | (0.05) | (0.39) | (0.08) | (0.45) | (0.23) | (1.43) | (0.56) | (0.89) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (12.05%) | (25.02%) | (19.25%) | (14.18%) | (7.84%) | (6.82%) | (6.63%) | (11.65%) | (11.64%) | (1.26%) | |
| (3.72%) | (8.24%) | (7.19%) | (6.28%) | (3.88%) | (3.32%) | (3.26%) | (6.76%) | (8.55%) | (1.02%) | |
ROIC |
(9.51%) | (20.24%) | (25.17%) | (10.94%) | (15.22%) | (10.46%) | (13.73%) | (17.75%) | (10.79%) | (3.31%) |
Return on Tangible Assets |
(488.90%) | (126.86%) | (77.52%) | (31.69%) | (13.06%) | (13.42%) | (13.22%) | (21.70%) | (15.49%) | (1.84%) |
Average Days of Receivables |
138.92 | 112.79 | 90.05 | 114.37 | 69.76 | 120.67 | 83.42 | 97.57 | 74.46 | 81.01 |
Research and Development Expense of Revenue |
12.50% | 12.72% | 14.75% | 15.92% | 15.80% | 15.42% | 19.97% | 25.82% | 10.40% | 9.66% |
Selling, General and Administrative Expense of Revenue |
69.73% | 74.34% | 73.58% | 63.89% | 68.91% | 66.67% | 73.43% | 82.32% | 75.68% | 69.99% |
Intangible Assets out of Total Assets |
0.19 | 0.25 | 0.29 | 0.34 | 0.29 | 0.30 | 0.30 | 0.31 | 0.23 | 0.24 |
Share Based Compensation of Revenue |
0.92% | 0.80% | 0.92% | 1.07% | 2.06% | 2.80% | 4.32% | 4.65% | 3.62% | 2.58% |
Graham Net Nets |
(0.26) | (0.50) | (0.64) | (0.33) | 0.06 | 0.01 | (0.04) | 0.02 | 0.35 | 0.48 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(4.77%) | (19.83%) | (23.68%) | (16.45%) | (5.14%) | (7.46%) | (4.47%) | (7.46%) | (7.09%) | (1.03%) |
Free Cash Flow Yield |
8.03% | (2.38%) | 21.32% | 18.96% | 8.60% | 7.38% | 2.57% | (1.23%) | (1.82%) | (1.64%) |
Revenue per Share |
3.00 | 2.69 | 2.77 | 2.88 | 2.41 | 2.47 | 2.23 | 1.88 | 2.59 | 2.03 |
Operating CF per Share |
0.33 | (0.04) | 0.43 | 0.58 | 0.43 | 0.36 | 0.20 | 0.20 | (0.03) | 0.04 |
Capex per Share |
(0.01) | (0.01) | (0.03) | (0.14) | (0.02) | (0.14) | (0.07) | (0.27) | (0.09) | (0.13) |
Free Cash Flow per Share |
0.32 | (0.06) | 0.39 | 0.44 | 0.40 | 0.22 | 0.13 | (0.07) | (0.13) | (0.10) |
Cash per Share |
0.77 | 1.28 | 1.28 | 1.36 | 1.81 | 1.63 | 1.83 | 2.32 | 3.15 | 3.09 |
Shareholders Equity per Share |
1.65 | 1.60 | 2.05 | 2.47 | 2.86 | 3.09 | 3.32 | 3.56 | 4.02 | 4.50 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.65 | 1.60 | 2.05 | 2.47 | 2.86 | 3.09 | 3.32 | 3.56 | 4.02 | 4.50 |
Free Cash Flow |
4.75 | (0.79) | 5.64 | 6.38 | 5.99 | 3.30 | 2.04 | (1.16) | (2.05) | (1.56) |
Working Capital |
0.32 | 4.83 | 7.73 | 17.29 | 26.41 | 24.30 | 26.01 | 31.31 | 50.99 | 50.75 |
Capital Expenditures |
(0.18) | (0.18) | (0.45) | (2.07) | (0.35) | (2.11) | (1.02) | (4.28) | (1.49) | (2.13) |
Net Current Asset Value |
(15.22) | (16.59) | (16.80) | (11.08) | 3.83 | 0.38 | (3.30) | 1.99 | 39.37 | 45.26 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.05 | 0.01 | 0.06 | 0.03 | 0.15 | 0.04 | 0.06 |
Net Profit Margin |
(6.37%) | (17.11%) | (15.88%) | (13.26%) | (9.75%) | (8.92%) | (10.29%) | (23.73%) | (19.39%) | (2.86%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
15.66 | 17.67 | 22.51 | 18.76 | 10.41 | 8.27 | 5.89 | 3.87 | 5.01 | 5.16 |
Cash ROIC |
11.32% | (1.59%) | 9.49% | 11.33% | 6.89% | 5.52% | 2.34% | 2.09% | (0.88%) | 0.08% |
Accounts Receivable Turnover |
3.11 | 3.53 | 3.45 | 4.19 | 3.74 | 3.70 | 4.38 | 3.61 | 5.23 | 4.93 |
Accounts Payable Turnover |
0.41 | 0.47 | 0.49 | 0.89 | 0.77 | 0.74 | 0.70 | 0.60 | 0.87 | 1.09 |
Inventory Turnover |
1.30 | 1.53 | 0.84 | 1.00 | 0.92 | 0.89 | 0.71 | 0.64 | 1.22 | 1.24 |
Average Days of Payables |
1,016.49 | 771.14 | 844.58 | 433.07 | 399.37 | 565.08 | 491.51 | 672.96 | 444.69 | 492.28 |
Days of Inventory on Hand |
340.82 | 221.68 | 277.33 | 394.83 | 349.20 | 448.74 | 436.32 | 732.71 | 333.66 | 329.04 |
Average Receivables |
14.32 | 10.73 | 11.46 | 10.02 | 9.63 | 10.12 | 7.85 | 8.12 | 7.86 | 6.70 |
Average Payables |
16.24 | 13.98 | 12.43 | 10.23 | 11.52 | 11.69 | 10.54 | 10.04 | 8.51 | 5.46 |
Average Inventory |
5.11 | 4.30 | 7.24 | 9.15 | 9.53 | 9.75 | 10.47 | 9.41 | 6.05 | 4.82 |
Average Assets |
76.20 | 78.68 | 87.35 | 88.69 | 90.46 | 100.51 | 108.62 | 102.96 | 93.32 | 92.66 |
Average Common Equity |
23.55 | 25.90 | 32.62 | 39.29 | 44.74 | 48.98 | 53.33 | 59.75 | 68.52 | 74.97 |
Columns are period end dates